Evidence map›Paper›PMID 39347929›Full record

ReviewJournal of epidemiology and global health2024

Multicomponent Approaches to Reduce Multidrug-Resistant Organisms in Critical Care: Determining the Ideal Strategy.

Salma AlBahrani, Mustafa Saad, Jaber S Alqahtani, Zainab Almoosa, Mohammed Alabdulla, Mohammed Algezery, Sondos AlShehri, Jaffar A Al-Tawfiq

Abstract readReview
In one paragraph

Review in Journal of epidemiology and global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Salma AlBahraniInfectious Disease Unit, Specialty Internal Medicine, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Mustafa SaadDepartment of Infection Control, Alhasa, Saudi Arabia.
Jaber S AlqahtaniDepartment of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia.
Zainab AlmoosaInfectious Disease Department, Almoosa specialist Hospital, Alhasa, Saudi Arabia.
Mohammed AlabdullaInfectious Disease Department, Almoosa specialist Hospital, Alhasa, Saudi Arabia.
Mohammed AlgezeryInfection control Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Sondos AlShehriQuality Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Jaffar A Al-TawfiqInfectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia. jaffar.tawfiq@jhah.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although there is ample proof of the advantages of infection prevention and Control (IPC) in acute-care hospitals, there is still some questions about the efficacy of IPC interventions for multidrug-resistant organisms (MDROs), and there is a need for the development of evidence-based practices. No healthcare facility has found a single effective technique to reduce MDRO. However, a multicomponent intervention that included improved barrier protection, chlorhexidine bathing, microbiological monitoring, and staff involvement significantly decreased the likelihood of infection in the patient surroundings with multidrug-resistant organisms. A practical strategy suited to reducing the burden of MDROs and their transmission potential in the critical care unit must be established in light of the global development of AMR. In this review, we summarize key findings of a multicomponent approaches to reduce MDROs in critical care units.

Indexed as

Critical CareCross InfectionDrug Resistance, MultipleInfection ControlHumansIntensive Care UnitsAntibiotic useAntimicrobial resistanceCREESBLInfection preventionMDROMRSA

Identifiers

PMID39347929
PMCPMC11652424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.